A comprehensive view of Biopharmaceuticals/Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Bionova Scientific to increase biologics manufacturing capabilities at 36,000 square-foot Fremont, California, plant; the facility is able to produce multiple monoclonal antibodies and other recombinant proteins simultaneously
Published:
February 03, 2023
by FiercePharma
|
BioNTech complete construction of company’s first proprietary plasmid DNA manufacturing facility in Marburg, Germany; new facility will strengthen firm’s manufacturing capabilities, allow BioNTech to make the majority of its DNA plasmids in house
Published:
February 02, 2023
by GlobeNewswire
|
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
Published:
February 02, 2023
by Moderna Inc.
|
Purification of Antibodies Using Novel Convecdiff Membranes Part 2: Robust Performance at Comparable Product Quality
Published:
February 02, 2023
by Biopharm International
|
AGC Biologics in Bothell to produce new diabetes treatment
Published:
February 01, 2023
by Daily Herald, The (Everett, WA)
|
Ask us about our Government & Public Policy market view
Trending Chart
Interactive chart with headline count